Cytotoxicity mediation of cells evidencing surface expression of MCSP
US7393531B2 · kind B2 · utility
6Cited by
23References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 2004 |
| Grant date | Jul 1, 2008 |
| Priority date | — |
| Expiry date | Mar 13, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the diagnosis and treatment of cancerous diseases, particularly to the mediation of cytotoxicity of tumor cells; and most particularly to the use of cancerous disease modifying antibodies (CDMAB), optionally in combination with one or more chemotherapeutic agents, as a means for initiating the cytotoxic response. The invention further relates to binding assays which utilize the CDMABs of the instant invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.